Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer.
This article discusses the molecular characteristics of the main lung cancer subtypes and discusses the current guidelines and novel targeted therapies, including checkpoint immunotherapy.
PMID: 32005431 [PubMed - in process]
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Ruiz-Cordero R, Devine WP Tags: Surg Pathol Clin Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Genetics | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer